Mylan Inc. (MYL) Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories Limited (MAXL.BO)
11/11/2009 8:25:40 AM
More...
|
Mylan Inc. (MYL) Posts Net Loss, But Results Top Street View
10/29/2009 6:15:23 AM
More...
|
Mylan Inc. (MYL) Declares Quarterly Preferred Stock Dividend
10/20/2009 10:44:25 AM
More...
|
Mylan Inc. (MYL) Resolves Longstanding Dispute with DOJ Regarding Certain Medicaid Rebate Classifications from 2000 Through 2004
10/19/2009 9:35:58 AM
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Sues Mylan Inc. (MYL) Alleging Copaxone Patent Infringement
10/19/2009 7:00:43 AM
More...
|
Mylan Inc. (MYL) Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
10/15/2009 8:35:37 AM
More...
|
Mylan Inc. (MYL) Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
10/15/2009 8:14:00 AM
More...
|
Mylan Inc. (MYL) Announces Settlement Agreement Related to Vfend(R) First-to-File Opportunity
10/14/2009 11:41:36 AM
More...
|
Pharma Giants On Look-out For Cure Against 'No Frills Drugs'; GlaxoSmithKline (GSK), Bayer AG (BAY.F), AstraZeneca AB. And Novartis AG Meet to Discuss Pharmaceutical Futures
10/1/2009 2:18:01 PM
More...
|
Mylan Inc. (MYL) Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
9/30/2009 9:58:36 AM
More...
|
|